ANG Lifesciences India Limited (ANG.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹33.38 (+1.64%) as of
Key statistics
- Market cap
- 435.89M
- EPS (TTM)
- -10.18
- Dividend yield
- 0.00%
- 52-week range
- 17.63 – 49.69
- Beta
- 0.76
- Revenue (TTM)
- 835.87M
- Profit margin
- -15.94%
- Volume
- 520.00
About ANG Lifesciences India Limited
ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company also offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions. ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Amritsar, India
- Employees
- 379
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.
Related stocks
- KESAR TERMINALS & INFRASTRUCTU (KTIL.BO)
- TAPI FRUIT PROCESSING LTD (TAPIFRUIT-SM.NS)
- KREBS BIOCHEMICALS & INDUSTRIE (KREBSBIO.BO)
- KCL Infra Projects Limited (KCLINFRA.BO)
- VLS FINANCE LTD. (VLSFINANCE.BO)
- INNOVATIVE TYRE & TUBE LT (ITTL-SM.NS)
- NAHAR POLYFILMS LTD. (NAHARPOLY.BO)
- SAVERA INDUSTRIES LTD. (SAVERA.BO)